Gene Panel Market to Hit USD 16.42 Billion by 2033 | Boasting a 17.8% CAGR

According to Nova One Advisor, the global gene panel market size was USD 3.19 billion in 2023, calculated at USD 3.76 billion in 2024 and is expected to reach around USD 16.42 billion by 2033, expanding at a CAGR of 17.8% from 2024 to 2033.

The number of congenital disorders, coupled with an unprecedented increase in the number of cancer cases across the globe, is anticipated to drive the market. Early diagnosis of chromosomal disorders enables timely prognosis and therapeutic steps to be taken so as to retard the symptoms and improve the quality of life.

Furthermore, an increase in hereditary level understanding and a rise in the need for genetic screening, personalized medicine, risk analysis, and prognostics are anticipated to drive the market. A specific group of genes needs to be sequenced and analyzed to understand the genetic predisposition of a disease condition. The panels help in sequencing specific genes that are known to be causative of the disease condition. There are many predesigned panels for particular disease conditions along with options for customization. There also have been consistent research efforts to devise novel gene panels to efficiently diagnose a wide spectrum of genetic disorders.

For instance, INVIEW Liquid Biopsy Onco-profiling is an all-inclusive comprehensive cancer gene panel for examination using liquid biopsy samples like blood. Customizable gene panels are also available that can be customized based on specific requirements. For instance, QIAseq multimodal custom panel is a customizable gene panel that is able to profile variant DNA, RNA fusion, and gene expression patterns from a single sample input.

The COVID-19 pandemic has significantly disrupted the delivery of effective healthcare services, including genetic counseling and genetic testing services. There are efforts across the U.S. to ensure re-igniting genetic testing, at least for pre-implantation screening. However, the ramping up of genetic screening for cancer has also become a part of the mission of cancer societies across the globe.

Moreover, many researchers and clinicians believe that there is a strong necessity for the enforcement of genetic screening procedures to bring down the mortality rate due to genetic disorders, and therefore there will be a rise in the demand for gene panels during the forecast period. For instance, all those born in the U.S. are compulsorily screened using a blood sample for certain genetic, endocrine, metabolic, hearing, and critical congenital heart disorders.

?Full Report is Ready | Ask here for Sample Copy@? https://www.novaoneadvisor.com/report/sample/8785

Gene Panel Market Report Highlights

• By products & services, the test kits segment held the largest share in 2023 due to the utilitarian benefits that a test kit could offer to clinicians, researchers, and the normal population. Ready-to-use kits and self-administrable diagnostic kits are increasingly trending these days
• By technique, the hybridization-based approach is in the growth phase due to the reliability of outcomes, though the technique is expensive and time-consuming. Gene panels are usually designed for the analysis of several genes and the hybridization technique is conducive to this concept of gene panel testing
• By design, predesigned gene panels dominated the market in 2023. This is because predesigned gene panels are preferred over customizable gene panels for diagnostic utility because predesigned panels are backed by research for outcome reliability
• By application, the cancer risk assessment segment is expected to grow lucratively during the forecast period due to a rise in the number of cancer cases and increased recommendations for cancer screening across different countries
• North America dominated the global market in 2023 owing to the increasing demand for genetic screening and early cancer screening, the presence of key players, the rising prevalence of cancer, and rising recommendations for newborn screening

Immediate Delivery Available, Get Full Access@ ??https://www.novaoneadvisor.com/report/checkout/8785

Gene Panel Market By Regional Insights & Trends

North America gene panel market dominated the global gene panel market with a share of 36.17% in 2023. The research on cancer and inherited rare diseases in the region has witnessed a significant surge, accompanied by a notable increase in the number of NGS-based and clinical applications. Moreover, the presence of leading NGS providers in this region, coupled with the growing government support for genomics research, has further propelled advancements in this field.

U.S. Gene Panel Market Trends

The gene panel market in the U.S. dominated the North America gene panel market with a share of 71.7% in 2023 due to comprehensive studies conducted in multiple research facilities, jointly sponsored by academic institutions, pharmaceutical companies, and the National Cancer Institute, facilitating widespread adoption and growth.

Europe Gene Panel Market Trends

Europe gene panel market was identified as a profitable region in the industry, driven by supportive government policies, regulations, and incentives that promote the adoption of gene panel technology, such as subsidies for renewable energy initiatives and carbon pricing mechanisms, which contribute to market growth.

The gene panel market in the UK is impacted by the British government’s demonstration of a resolute dedication to the progression of genomic healthcare and research. Notably, the NHS in England has become the pioneer in providing whole genome sequencing as a standard component of routine care, making it the first healthcare service globally to do so.

Asia Pacific Gene Panel Market Trends

Asia Pacific gene panel market is projected to register the fastest CAGR of 19.6% over the forecast period, driven by increasing healthcare expenditure, technological advancements, and growing demand for genetic testing. The region is witnessing increased adoption for applications like cancer risk assessment, congenital disease diagnosis, and pharmacogenomics, fueled by expanding healthcare infrastructure, awareness, and rising incidence of genetic disorders and cancer.

The gene panel market in China is expected to grow rapidly in the coming years due to the growing demand of genetic screening. Genetic panels have become a popular choice for genetic screening due to their ability to efficiently and affordably screen for multiple genetic mutations at once.

Gene Panel Market Key Company Insights

Key market players are competing on product innovation, pricing, and strategic partnerships. The competitive landscape in the industry is dynamic, with constant new product launches and geographic expansions to maintain market positions.

GenScript offers clients the opportunity to verify the effectiveness of antibodies in their specific application prior to proceeding with the sequencing of desired clones for recombinant antibody production.

Illumina aims to utilize cutting-edge technologies in order to analyze genetic variation and function, enabling studies that were previously unimaginable. It provides adaptable and scalable solutions to cater to the customers' requirements.

Gene Panel Market Top Key Companies:

• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• Agilent Technologies, Inc.
• QIAGEN N.V.
• BGI Genomics Co., Ltd.
• Eurofins Scientific SE
• GENEWIZ, Inc.
• Novogene Corporation
• Personalis, Inc.
• F. Hoffmann-La Roche Ltd.

Gene Panel Market Recent Development

• In May 2024, 10x Genomics introduced the Xenium Prime 5K Pan-Tissue and Pathways panel, revolutionizing single-cell analysis with a major plex increase and industry-best speed and throughput, allowing for detailed exploration of cellular biology and disease mechanisms.
• In May 2023, Vizgen launched two predesigned MERFISH gene panels, PanCancer Pathways and PanNeuro Cell Type, at the AACR 2023, providing a convenient starting point for researchers to explore spatial genomics. The panels feature curated lists of genes from published literature and databases, enabling studies on cancer and brain biology.
• In April 2023, Agilent Technologies, Inc. announced the launch of the SureSelect Cancer CGP Assay, an NGS panel for comprehensive genomic profiling of solid tumors. The assay features 679 globally curated genes, including somatic variants and immuno-oncology biomarkers, and can be automated for efficient workflow and high-performance results.

Gene Panel Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the Gene Panel market.

By Product & Services?

• Test Kits
• Testing Services

By Technique?

• Amplicon-based Approach
• Hybridization-based Approach

By Design?

• Predesigned Gene Panel
• Customized Gene Panel

By Application?

• Cancer Risk Assessment
• Syndrome Specific
• High Penetrance
• High & Moderate Penetrance
• Comprehensive Cancer Risk
• Diagnosis of Congenital Diseases
• Pharmacogenetics
• Other Applications

By End Use?

• Academic & Research Institutes
• Hospital & Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)

Reasons to Purchase this Report

? Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors

? Provision of market value (USD Billion) data for each segment and sub-segment

? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

? The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

? Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

? Provides insight into the market through Value Chain

? Market dynamics scenario, along with growth opportunities of the market in the years to come

? 6-month post-sales analyst support

Immediate Delivery Available | Buy This Premium Research ??https://www.novaoneadvisor.com/report/checkout/8785

Call: USA: +1 650 460 3308 | IND: +91 87933 22019 |Europe: +44 2080772818

Email: [email protected]

Web: https://www.novaoneadvisor.com/

You can place an order or ask any questions, please feel free to contact at?[email protected] ?| +1 650 460 3308